 | • レポートコード：MRC2-11QY11550 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は嚢胞性線維症（ムコビスコイドーシス）検査のグローバル市場について調査・分析したレポートです。種類別（胸部理学療法（CPT）、抗生物質消費、肺移植・体位ドレナージ）市場規模、用途別（病院、外来手術センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別嚢胞性線維症（ムコビスコイドーシス）検査の競争状況、市場シェア ・世界の嚢胞性線維症（ムコビスコイドーシス）検査市場：種類別市場規模 2015年-2020年（胸部理学療法（CPT）、抗生物質消費、肺移植・体位ドレナージ） ・世界の嚢胞性線維症（ムコビスコイドーシス）検査市場：種類別市場規模予測 2021年-2026年（胸部理学療法（CPT）、抗生物質消費、肺移植・体位ドレナージ） ・世界の嚢胞性線維症（ムコビスコイドーシス）検査市場：用途別市場規模 2015年-2020年（病院、外来手術センター、その他） ・世界の嚢胞性線維症（ムコビスコイドーシス）検査市場：用途別市場規模予測 2021年-2026年（病院、外来手術センター、その他） ・北米の嚢胞性線維症（ムコビスコイドーシス）検査市場分析：米国、カナダ ・ヨーロッパの嚢胞性線維症（ムコビスコイドーシス）検査市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの嚢胞性線維症（ムコビスコイドーシス）検査市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の嚢胞性線維症（ムコビスコイドーシス）検査市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの嚢胞性線維症（ムコビスコイドーシス）検査市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Vertex Pharmaceuticals、Abbott、Pfizer、NovaBiotics、Cystic Fibrosis Foundation、Galapagos ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Cystic Fibrosis, also known as mucoviscoidosis, is an inherited genetic disorder that affects the secretory glands, including mucus and sweat glands. It mainly affects the lungs and digestive system. An individual suffering from cystic fibrosis show characteristic symptoms, such as, secretion of thick and sticky mucus. The disease develops over a period of time in the lungs and blocks the tubes that carry air in and out. Increased secretion of thick mucus accelerates the growth of bacteria and hence, gives rise to serious lung infections. Some of the major symptoms of cystic fibrosis include persistent cough, constant lung infection, salty tasting skin, problem in breathing, bulky stools, difficulty in bowel movements, poor growth and poor weight gain. Some of the tests available for cystic fibrosis are newborn screening, sweat test, chest x-ray, lung function tests, and genetic testing. Cystic fibrosis can be divided into three segments, namely, cystic fibrosis mutations, curable type of cystic fibrosis, and rare type of cystic fibrosis. Some of the treatment methods for cystic fibrosis are chest physical therapy (CPT), exercise, consumption of antibiotics, lung transplant and postural drainage.
Major driving factors for the growth of the cystic fibrosis market are increasing number of patients suffering from cystic fibrosis, rising need and demand for sophisticated testing tools, and increased government funding for the development of genetic testing. Moreover, every company wants to grow and develop by using pharmacogenomic diagnostic tools, so that they have an enviable position in the existing market. Rapid adoption of potentially advanced tests to diagnose cystic fibrosis and increasing awareness and affordability of the people across geographies will continually provide growth towards this market. On the other hand, factors like huge amount of capital involved and few adverse effects like pulmonary exacerbations and weight gain would most likely impede the growth of this market.
Market Analysis and Insights: Global Cystic Fibrosis(Mucoviscoidosis)Testing Market
The global Cystic Fibrosis(Mucoviscoidosis)Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Cystic Fibrosis(Mucoviscoidosis)Testing Scope and Market Size
Cystic Fibrosis(Mucoviscoidosis)Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cystic Fibrosis(Mucoviscoidosis)Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Vertex Pharmaceuticals
Abbott
Pfizer
NovaBiotics
Cystic Fibrosis Foundation
Galapagos
…
Market segment by Type, the product can be split into
Chest Physical Therapy (CPT)
Consumption Of Antibiotics
Lung Transplant And Postural Drainage
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cystic Fibrosis(Mucoviscoidosis)Testing Revenue
1.4 Market by Type
1.4.1 Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chest Physical Therapy (CPT)
1.4.3 Consumption Of Antibiotics
1.4.4 Lung Transplant And Postural Drainage
1.5 Market by Application
1.5.1 Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Perspective (2015-2026)
2.2 Global Cystic Fibrosis(Mucoviscoidosis)Testing Growth Trends by Regions
2.2.1 Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cystic Fibrosis(Mucoviscoidosis)Testing Historic Market Share by Regions (2015-2020)
2.2.3 Cystic Fibrosis(Mucoviscoidosis)Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cystic Fibrosis(Mucoviscoidosis)Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Cystic Fibrosis(Mucoviscoidosis)Testing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Cystic Fibrosis(Mucoviscoidosis)Testing Players by Market Size
3.1.1 Global Top Cystic Fibrosis(Mucoviscoidosis)Testing Players by Revenue (2015-2020)
3.1.2 Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Concentration Ratio
3.2.1 Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cystic Fibrosis(Mucoviscoidosis)Testing Revenue in 2019
3.3 Cystic Fibrosis(Mucoviscoidosis)Testing Key Players Head office and Area Served
3.4 Key Players Cystic Fibrosis(Mucoviscoidosis)Testing Product Solution and Service
3.5 Date of Enter into Cystic Fibrosis(Mucoviscoidosis)Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cystic Fibrosis(Mucoviscoidosis)Testing Historic Market Size by Type (2015-2020)
4.2 Global Cystic Fibrosis(Mucoviscoidosis)Testing Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2015-2020)
5.2 Global Cystic Fibrosis(Mucoviscoidosis)Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size (2015-2020)
6.2 Cystic Fibrosis(Mucoviscoidosis)Testing Key Players in North America (2019-2020)
6.3 North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2015-2020)
6.4 North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Size (2015-2020)
7.2 Cystic Fibrosis(Mucoviscoidosis)Testing Key Players in Europe (2019-2020)
7.3 Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2015-2020)
7.4 Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2015-2020)
8 China
8.1 China Cystic Fibrosis(Mucoviscoidosis)Testing Market Size (2015-2020)
8.2 Cystic Fibrosis(Mucoviscoidosis)Testing Key Players in China (2019-2020)
8.3 China Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2015-2020)
8.4 China Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Cystic Fibrosis(Mucoviscoidosis)Testing Market Size (2015-2020)
9.2 Cystic Fibrosis(Mucoviscoidosis)Testing Key Players in Japan (2019-2020)
9.3 Japan Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2015-2020)
9.4 Japan Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Cystic Fibrosis(Mucoviscoidosis)Testing Market Size (2015-2020)
10.2 Cystic Fibrosis(Mucoviscoidosis)Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2015-2020)
11 India
11.1 India Cystic Fibrosis(Mucoviscoidosis)Testing Market Size (2015-2020)
11.2 Cystic Fibrosis(Mucoviscoidosis)Testing Key Players in India (2019-2020)
11.3 India Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2015-2020)
11.4 India Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size (2015-2020)
12.2 Cystic Fibrosis(Mucoviscoidosis)Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2015-2020)
12.4 Central & South America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Vertex Pharmaceuticals
13.1.1 Vertex Pharmaceuticals Company Details
13.1.2 Vertex Pharmaceuticals Business Overview
13.1.3 Vertex Pharmaceuticals Cystic Fibrosis(Mucoviscoidosis)Testing Introduction
13.1.4 Vertex Pharmaceuticals Revenue in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2015-2020))
13.1.5 Vertex Pharmaceuticals Recent Development
13.2 Abbott
13.2.1 Abbott Company Details
13.2.2 Abbott Business Overview
13.2.3 Abbott Cystic Fibrosis(Mucoviscoidosis)Testing Introduction
13.2.4 Abbott Revenue in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2015-2020)
13.2.5 Abbott Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer Cystic Fibrosis(Mucoviscoidosis)Testing Introduction
13.3.4 Pfizer Revenue in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 NovaBiotics
13.4.1 NovaBiotics Company Details
13.4.2 NovaBiotics Business Overview
13.4.3 NovaBiotics Cystic Fibrosis(Mucoviscoidosis)Testing Introduction
13.4.4 NovaBiotics Revenue in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2015-2020)
13.4.5 NovaBiotics Recent Development
13.5 Cystic Fibrosis Foundation
13.5.1 Cystic Fibrosis Foundation Company Details
13.5.2 Cystic Fibrosis Foundation Business Overview
13.5.3 Cystic Fibrosis Foundation Cystic Fibrosis(Mucoviscoidosis)Testing Introduction
13.5.4 Cystic Fibrosis Foundation Revenue in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2015-2020)
13.5.5 Cystic Fibrosis Foundation Recent Development
13.6 Galapagos
13.6.1 Galapagos Company Details
13.6.2 Galapagos Business Overview
13.6.3 Galapagos Cystic Fibrosis(Mucoviscoidosis)Testing Introduction
13.6.4 Galapagos Revenue in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2015-2020)
13.6.5 Galapagos Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Cystic Fibrosis(Mucoviscoidosis)Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Cystic Fibrosis(Mucoviscoidosis)Testing Revenue
Table 3. Ranking of Global Top Cystic Fibrosis(Mucoviscoidosis)Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chest Physical Therapy (CPT)
Table 6. Key Players of Consumption Of Antibiotics
Table 7. Key Players of Lung Transplant And Postural Drainage
Table 8. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Regions (2015-2020)
Table 12. Global Cystic Fibrosis(Mucoviscoidosis)Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Cystic Fibrosis(Mucoviscoidosis)Testing Market Growth Strategy
Table 18. Main Points Interviewed from Key Cystic Fibrosis(Mucoviscoidosis)Testing Players
Table 19. Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue by Players (2015-2020) (Million US$)
Table 20. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Players (2015-2020)
Table 21. Global Top Cystic Fibrosis(Mucoviscoidosis)Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cystic Fibrosis(Mucoviscoidosis)Testing as of 2019)
Table 22. Global Cystic Fibrosis(Mucoviscoidosis)Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Cystic Fibrosis(Mucoviscoidosis)Testing Product Solution and Service
Table 25. Date of Enter into Cystic Fibrosis(Mucoviscoidosis)Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2015-2020) (Million US$)
Table 28. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size Share by Type (2015-2020)
Table 29. Global Cystic Fibrosis(Mucoviscoidosis)Testing Revenue Market Share by Type (2021-2026)
Table 30. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size Share by Application (2015-2020)
Table 31. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2015-2020) (Million US$)
Table 32. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size Share by Application (2021-2026)
Table 33. North America Key Players Cystic Fibrosis(Mucoviscoidosis)Testing Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Cystic Fibrosis(Mucoviscoidosis)Testing Market Share (2019-2020)
Table 35. North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2015-2020) (Million US$)
Table 36. North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Type (2015-2020)
Table 37. North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2015-2020) (Million US$)
Table 38. North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Application (2015-2020)
Table 39. Europe Key Players Cystic Fibrosis(Mucoviscoidosis)Testing Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Cystic Fibrosis(Mucoviscoidosis)Testing Market Share (2019-2020)
Table 41. Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Type (2015-2020)
Table 43. Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Application (2015-2020)
Table 45. China Key Players Cystic Fibrosis(Mucoviscoidosis)Testing Revenue (2019-2020) (Million US$)
Table 46. China Key Players Cystic Fibrosis(Mucoviscoidosis)Testing Market Share (2019-2020)
Table 47. China Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2015-2020) (Million US$)
Table 48. China Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Type (2015-2020)
Table 49. China Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2015-2020) (Million US$)
Table 50. China Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Application (2015-2020)
Table 51. Japan Key Players Cystic Fibrosis(Mucoviscoidosis)Testing Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Cystic Fibrosis(Mucoviscoidosis)Testing Market Share (2019-2020)
Table 53. Japan Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Type (2015-2020)
Table 55. Japan Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Cystic Fibrosis(Mucoviscoidosis)Testing Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Cystic Fibrosis(Mucoviscoidosis)Testing Market Share (2019-2020)
Table 59. Southeast Asia Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Type (2015-2020)
Table 61. Southeast Asia Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Application (2015-2020)
Table 63. India Key Players Cystic Fibrosis(Mucoviscoidosis)Testing Revenue (2019-2020) (Million US$)
Table 64. India Key Players Cystic Fibrosis(Mucoviscoidosis)Testing Market Share (2019-2020)
Table 65. India Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2015-2020) (Million US$)
Table 66. India Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Type (2015-2020)
Table 67. India Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2015-2020) (Million US$)
Table 68. India Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Cystic Fibrosis(Mucoviscoidosis)Testing Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Cystic Fibrosis(Mucoviscoidosis)Testing Market Share (2019-2020)
Table 71. Central & South America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Type (2015-2020)
Table 73. Central & South America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Application (2015-2020)
Table 75. Vertex Pharmaceuticals Company Details
Table 76. Vertex Pharmaceuticals Business Overview
Table 77. Vertex Pharmaceuticals Product
Table 78. Vertex Pharmaceuticals Revenue in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2015-2020) (Million US$)
Table 79. Vertex Pharmaceuticals Recent Development
Table 80. Abbott Company Details
Table 81. Abbott Business Overview
Table 82. Abbott Product
Table 83. Abbott Revenue in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2015-2020) (Million US$)
Table 84. Abbott Recent Development
Table 85. Pfizer Company Details
Table 86. Pfizer Business Overview
Table 87. Pfizer Product
Table 88. Pfizer Revenue in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2015-2020) (Million US$)
Table 89. Pfizer Recent Development
Table 90. NovaBiotics Company Details
Table 91. NovaBiotics Business Overview
Table 92. NovaBiotics Product
Table 93. NovaBiotics Revenue in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2015-2020) (Million US$)
Table 94. NovaBiotics Recent Development
Table 95. Cystic Fibrosis Foundation Company Details
Table 96. Cystic Fibrosis Foundation Business Overview
Table 97. Cystic Fibrosis Foundation Product
Table 98. Cystic Fibrosis Foundation Revenue in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2015-2020) (Million US$)
Table 99. Cystic Fibrosis Foundation Recent Development
Table 100. Galapagos Company Details
Table 101. Galapagos Business Overview
Table 102. Galapagos Product
Table 103. Galapagos Revenue in Cystic Fibrosis(Mucoviscoidosis)Testing Business (2015-2020) (Million US$)
Table 104. Galapagos Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Type: 2020 VS 2026
Figure 2. Chest Physical Therapy (CPT) Features
Figure 3. Consumption Of Antibiotics Features
Figure 4. Lung Transplant And Postural Drainage Features
Figure 5. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Others Case Studies
Figure 9. Cystic Fibrosis(Mucoviscoidosis)Testing Report Years Considered
Figure 10. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Regions: 2020 VS 2026
Figure 12. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Cystic Fibrosis(Mucoviscoidosis)Testing Market Share by Players in 2019
Figure 15. Global Top Cystic Fibrosis(Mucoviscoidosis)Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cystic Fibrosis(Mucoviscoidosis)Testing as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Cystic Fibrosis(Mucoviscoidosis)Testing Revenue in 2019
Figure 17. North America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Cystic Fibrosis(Mucoviscoidosis)Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
特発性肺線維症（IPF）の世界市場（～2026年） Idiopathic pulmonary fibrosis is a condition in which the tissues in the lungs become thick and stiff over time. As a result of thickening of lung tissues, brain and other organs are unable receive optimum oxygen. An increase in the incidence and prevalence of fibrotic diseases is the primary driver…- 筋骨格診断検査の世界市場（～2026年） A doctor can diagnose the musculoskeletal disorder by physical examination or with the help of various laboratory and imaging tests. Every procedure has its own diagnostic application such as DXA is more accurate for measuring bone density, CT and MRI provide more detail and the exact location of da…
- 土壌肥沃度試験の世界市場（～2026年） Soil fertility testing is the technique used to test the physical and chemical constituent of soil. The global fertility testing market is expected to witness robust growth over the forecast period due to the increasing population coupled with rising need to maintain the soil fertility. Market Analy…
- フィブリノーゲン（FIB）検査の世界市場（～2026年） A fibrinogen activity test is also known as a Factor I assay. It's used to determine the level of fibrinogen in your blood. The market growth is mainly attributed to development of various point-of-care diagnostic tests being developed for fibrinogen testing. Market Analysis and Insights: Global Fib…
- 抗酸菌（AFB）検査の世界市場（～2026年） Market Analysis and Insights: Global Acid-Fast Bacillus (AFB) Testing Market The global Acid-Fast Bacillus (AFB) Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Acid-Fast Bacillus (AFB) Testing Scope and Market…